small studies may overestimate the effect sizes in critical care meta-analyses a meta-epidemiological study小研究可能高估了尺度效应在危重病荟萃分析meta-epidemiological研究.pdf
文本预览下载声明
Zhang et al. Critical Care 2013, 17:R2
/content/17/1/R2
RESEARCH Open Access
Small studies may overestimate the effect sizes in
critical care meta-analyses: a meta-
epidemiological study
*
Zhongheng Zhang , Xiao Xu and Hongying Ni
Abstract
Introduction: Small-study effects refer to the fact that trials with limited sample sizes are more likely to report
larger beneficial effects than large trials. However, this has never been investigated in critical care medicine. Thus,
the present study aimed to examine the presence and extent of small-study effects in critical care medicine.
Methods: Critical care meta-analyses involving randomized controlled trials and reported mortality as an outcome
measure were considered eligible for the study. Component trials were classified as large (≥100 patients per arm)
and small (100 patients per arm) according to their sample sizes. Ratio of odds ratio (ROR) was calculated for
each meta-analysis and then RORs were combined using a meta-analytic approach. ROR1 indicated larger
beneficial effect in small trials. Small and large trials were compared in methodological qualities including
sequence generating, blinding, allocation concealment, intention to treat and sample size calculation.
Results: A total of 27 critical care meta-analyses involving 317 trials were included. Of them, five meta-analyses
showed statistically significant RORs 1, and other meta-analyses did not reach a statistical significance. Overall, the
pooled ROR was 0.60 (95% CI: 0.53 to 0.68); the heterogeneity was moderate with an I2 of 50.3% (chi-squared =
52.30; P = 0.002). Large trials showed significantly better reporting quality than small trials in terms of sequence
generating, allocation concealment, blinding, intention to treat, sample size calculation and incomplete follow-u
显示全部